Target intelligence / Profile preview

Nascent polypeptide-associated complex (NAC)

Target
NAC
Molecular classification
Molecular chaperone, Ribosome-associated protein, Transcription cofactor, Heterodimeric protein complex
01

Overview

The nascent polypeptide-associated complex (NAC) is a highly conserved, heterodimeric protein complex composed of alpha (NACA) and beta (BTF3) subunits that associates with the ribosome. It serves as one of the first cytosolic factors to encounter emerging nascent polypeptide chains, functioning as both a molecular chaperone and a gatekeeper for protein targeting. By competing with the signal recognition particle (SRP) for ribosome binding, NAC prevents the mistargeting of non-secretory proteins to the endoplasmic reticulum, thereby maintaining cellular proteostasis (Wiedmann et al., 1994; UniProt P15866, Q13765). Beyond its cytoplasmic role, subunits of NAC—particularly alpha-NAC—can translocate to the nucleus where they function as transcriptional co-activators for factors such as c-Jun, influencing developmental and proliferative pathways. In clinical contexts, the NAC complex is increasingly recognized for its role in disease progression. In cancer, NAC subunits are frequently overexpressed, promoting tumor cell survival and resistance to apoptosis by facilitating the folding of oncogenic proteins (Zhang et al., 2015). Conversely, in neurodegenerative conditions like Alzheimer's disease, a decrease in NAC levels or activity has been linked to the accumulation of misfolded protein aggregates and neuronal toxicity (Pezet et al., 2018). While it is currently considered a challenging therapeutic target due to its fundamental role in protein synthesis, experimental strategies focusing on the inhibition of its overexpression in oncology or the stabilization of its function in neurodegeneration are active areas of research.

Other names
Nascent polypeptide-associated complex subunit alpha (NACA)Nascent polypeptide-associated complex subunit beta (BTF3)Basic transcription factor 3Alpha-NAC/Beta-NAC complexRibosome-associated chaperone NAC
02

Mechanism of action

The complex functions by binding to the ribosome near the polypeptide exit tunnel to shield nascent chains from premature interactions and ensure correct targeting to organelles. It also acts as a transcriptional co-activator in the nucleus to modulate gene expression related to cell proliferation and survival.

03

Biological functions

Protein foldingProtein targetingProteostasisTranscription regulationPrevention of protein mistargeting to the endoplasmic reticulumApoptosis regulation
04

Disease associations

Cancer (e.g., lung, colorectal, and breast cancer)Neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease)Skeletal dysplasiaHuntington's disease
05

Safety considerations

Essential role in global proteostasis makes systemic inhibition potentially toxic to healthy cellsDual localization (cytoplasm and nucleus) complicates targeted inhibitionRisk of off-target effects on the signal recognition particle (SRP) pathway
06

Biomarkers

NACA protein expression levelsBTF3 mRNA levelsNAC complex stability/heterodimerization ratio

Beyond the preview

Go deeper on Nascent polypeptide-associated complex (NAC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nascent polypeptide-associated complex (NAC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call